Category: Health & Medicines > Medicines
Country/Region: China
Main Products: FURAZOLIDONG, FURALTADONG HCL, NITROFURAIONG, OLAQUINDOX, 5-NITROFURFURAL DIACETATE, FURAZOLIDONG
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2005, 2005
Legal Status: Third Party
Ownership: Private Limited
Employees: 501 - 1000 People
Factory Size: Above 100, 000 square meters
R&D Team Size: 51 - 100 People
Certifications: ISO17025
Contact Person: yanli wu
Designation: Businessman
Department: Administrative
Telephone: 86-13216178780
Main Markets: India (25%) Indonesia (20%) Philippines (17%) Canada (14%) Australia (12%)
Export Focus: Australia, Canada, Indonesia, India, Philippines
Contract Services: Design Service Offered
Annual Revenue: Approx More Than 1 Billion US Dollar
Registered Capital: US$5 Million - US$10 Million
Export Percentage: 21% - 30%
Payment Terms: Bank wire (T/T), Letter of Credit (L/C), Doc Against Acceptance (D/A), PayPal